Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone for Huntington's Disease Chorea
NCT04201834Phase 2Completed
- Sponsor
- University of Rochester
- Start
- Aug 2020
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of risperidone in Huntington's disease (HD), sponsored by University of Rochester. Started Aug 2020; status: completed.
02
Drugs
risperidone
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT04201834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04201834.